Derma Sciences core product, MEDIHONEY wound Record Making Activity honey Leptospermum, was found in a large randomized controlled clinical trials to significantly reduce the presence of methicillin-resistant Staphylococcus aureus (MRSA) in chronic wounds.
MRSA continues to dominate global headlines as a formidable nosocomial infections by killing thousands of patients each year and become a heavy burden on healthcare costs. The number of hospital admissions for MRSA has increased dramatically over the past ten years, with a 300% increase in 2005 over that in 2000, and 1000% more than in 1995. Conservative estimates suggest a global figure to 53 million people carrying MRSA. Bacteria resistant to common antibiotics such as methicillin, amoxicillin, penicillin, oxacillin, and quickly adapt to the new. Historically, MRSA was most common among people with weak immune systems living in hospitals or long-term care centers. However, increasingly present in healthy people, causing community-acquired MRSA.
Commenting, CEO Ed Quilty stated, "This study was presented last year at the European Management Association wounds, and we are delighted that work has been recognized in such a well-regarded peer-reviewed journal serving the wounds on the world market. MRSA, which is currently time coverage outside of hospitals and nursing homes in the community, claims more lives than AIDS in some countries. MEDIHONEY ability to eradicate the Superbug, as well as helping chronic wounds to progress towards healing, making it a truly unique product in the field of wounds. Together with our global partners to commercialize Comvita, have seen steady growth in sales and interest in the product line since its launch. "
Trial, 108-patient randomized and controlled clinical trials looked at venous leg ulcers that have proved non-healing under standard treatment (compression therapy). In the study, half of the patients had a common advanced wound care gel added to standard treatment, and half of them active Leptospermum Comvita (in Manuka) Honey (now marketed under the brand name MEDIHONEY) added. After four weeks, 70% MEDIHONEY treated wounds, compared with only 16% of the hydrogel treated wounds MRSA eradicated.
Published in this month, Wound care, research paper "Bacteriological Changes in venous leg ulcers squishy treated with Manuka Honey or Hydrogel: RCT", was written by leading investigators Georgina T. Gethin and Seamus working on the farm, both from the Royal College of Surgeons in Ireland . They concluded that for sloughy venous ulcers, "the effectiveness of honey in eliminating MRSA in such wounds a positive conclusion, which may have implications for the management of wounds and infection control."
Wound care is a major healthcare market with an estimated value of $ 10 billion in 2007 and is projected to grow to $ 12.5 billion in 2012. Global double-digit growth is ensured by several factors including an aging population, rising global incidence of diabetes and chronic vascular disorders, and steady progress in the technologies of wounds. The advanced wound care portion includes a wide range of disparate technologies that includes dressings and other devices.
The three main categories for seasoning: Traditional treatment of wounds, such as gauze, bandages wet, used to control the main issues of moisture and active dressings which include technologies that provide additional benefits, such as antimicrobial activity. Active category is the fastest among the three. A recent market research report on the details of Kalorama Information honey-based dressings emergence as a growing sub-category within active dressings.
MRSA continues to dominate global headlines as a formidable nosocomial infections by killing thousands of patients each year and become a heavy burden on healthcare costs. The number of hospital admissions for MRSA has increased dramatically over the past ten years, with a 300% increase in 2005 over that in 2000, and 1000% more than in 1995. Conservative estimates suggest a global figure to 53 million people carrying MRSA. Bacteria resistant to common antibiotics such as methicillin, amoxicillin, penicillin, oxacillin, and quickly adapt to the new. Historically, MRSA was most common among people with weak immune systems living in hospitals or long-term care centers. However, increasingly present in healthy people, causing community-acquired MRSA.
Commenting, CEO Ed Quilty stated, "This study was presented last year at the European Management Association wounds, and we are delighted that work has been recognized in such a well-regarded peer-reviewed journal serving the wounds on the world market. MRSA, which is currently time coverage outside of hospitals and nursing homes in the community, claims more lives than AIDS in some countries. MEDIHONEY ability to eradicate the Superbug, as well as helping chronic wounds to progress towards healing, making it a truly unique product in the field of wounds. Together with our global partners to commercialize Comvita, have seen steady growth in sales and interest in the product line since its launch. "
Trial, 108-patient randomized and controlled clinical trials looked at venous leg ulcers that have proved non-healing under standard treatment (compression therapy). In the study, half of the patients had a common advanced wound care gel added to standard treatment, and half of them active Leptospermum Comvita (in Manuka) Honey (now marketed under the brand name MEDIHONEY) added. After four weeks, 70% MEDIHONEY treated wounds, compared with only 16% of the hydrogel treated wounds MRSA eradicated.
Published in this month, Wound care, research paper "Bacteriological Changes in venous leg ulcers squishy treated with Manuka Honey or Hydrogel: RCT", was written by leading investigators Georgina T. Gethin and Seamus working on the farm, both from the Royal College of Surgeons in Ireland . They concluded that for sloughy venous ulcers, "the effectiveness of honey in eliminating MRSA in such wounds a positive conclusion, which may have implications for the management of wounds and infection control."
Wound care is a major healthcare market with an estimated value of $ 10 billion in 2007 and is projected to grow to $ 12.5 billion in 2012. Global double-digit growth is ensured by several factors including an aging population, rising global incidence of diabetes and chronic vascular disorders, and steady progress in the technologies of wounds. The advanced wound care portion includes a wide range of disparate technologies that includes dressings and other devices.
The three main categories for seasoning: Traditional treatment of wounds, such as gauze, bandages wet, used to control the main issues of moisture and active dressings which include technologies that provide additional benefits, such as antimicrobial activity. Active category is the fastest among the three. A recent market research report on the details of Kalorama Information honey-based dressings emergence as a growing sub-category within active dressings.
2 comments:
Thank you for all the information you provide on medihoney. I wanted to make sure the product I am using is good.
Heya¡my very first comment on your site. ,I have been reading your blog for a while and thought I would completely pop in and drop a friendly note. . It is great
stuff indeed. I also wanted to ask..is there a way to subscribe to your site via email?
MRSA Claims
Post a Comment